EDGAR Filing Documents for 0001213900-17-009973

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]

SEC Accession No. 0001213900-17-009973

Filing Date

2017-09-25

Accepted

2017-09-25 16:45:36

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	AMENDMENT TO FORM S-1	fs12017a1_adialpharma.htm	S-1/A	3789684
2	CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM	fs12017a1ex23-1_adialpharma.htm	EX-23.1	3003
3	GRAPHIC	ex23-1_001.jpg	GRAPHIC	10920
4	GRAPHIC	image001.jpg	GRAPHIC	7532
5	GRAPHIC	image002.jpg	GRAPHIC	10871
6	GRAPHIC	image003.jpg	GRAPHIC	10691
7	GRAPHIC	image004.jpg	GRAPHIC	19099
8	GRAPHIC	image005.jpg	GRAPHIC	15198
9	GRAPHIC	image006.jpg	GRAPHIC	23816
10	GRAPHIC	image007.jpg	GRAPHIC	10679
11	GRAPHIC	image008.jpg	GRAPHIC	10877
12	GRAPHIC	image009.jpg	GRAPHIC	10751
13	GRAPHIC	image010.jpg	GRAPHIC	12324
14	GRAPHIC	image011.jpg	GRAPHIC	5141
15	GRAPHIC	image012.jpg	GRAPHIC	5473
16	GRAPHIC	image013.jpg	GRAPHIC	10920
	Complete submission text file	0001213900-17-009973.txt		4021965

Mailing Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22902

Business Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22902 434-422-9800

ADial Pharmaceuticals, L.L.C. (Filer) CIK: 0001513525 (see all company filings)